Pharmacogenomic Pathways Underlying Variable Vedolizumab Response in Crohn’s Disease Patients: A Rare-Variant AnalysisBiljana Stankovic(University of Belgrade), Sonja Pavlović(University of Belgrade)BiomedicinesJanuary 17, 202610.3390/biomedicines14010203Cited by 1SaveCiteExport RISWatch citationsRelated PapersAssociation of Mitochondrial DNA Variants and Cognitive Impairment of Phenylketonuria Patients / POVEZANOST VARIJANTI U MITOHONDRIJALNOJ DNK I KOGNITIVNOG FENOTIPA KOD PACIJENATA SA FENILKETONURIJOM|Journal of Medical Biochemistry|2013|1